Table 2. Univariable and multivariable associations of ARGs shown with amoxicillin–clavulanic acid and piperacillin–tazobactam resistance.
| Univariable regression analysis for amoxicillin–clavulanic acid |
Multivariable regression analysis for amoxicillin–clavulanic acid |
Univariable regression analysis for piperacillin–tazobactam |
Multivariable regression analysis for piperacillin–tazobactam |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OR | p | aOR | p | OR | p | aOR | p | ||||
| bla TEM-1_1 | 1⋅00 (reference) | ⋅⋅ | 1⋅00 (reference) | ⋅⋅ | 1⋅00 (reference group) | ⋅⋅ | 1⋅00 (reference group) | ⋅⋅ | |||
| bla TEM-1_2 | 0⋅51 (0⋅31–0⋅83) | 0⋅0068 | 0⋅58 (0⋅35–0⋅95) | 0⋅031 | 0⋅69 (0⋅23–1⋅62) | 0⋅43 | 0⋅87 (0⋅28–2⋅04) | 0⋅76 | |||
| bla TEM-1_3 | 0⋅89 (0⋅70–1⋅11) | 0⋅30 | 1⋅00 (0⋅79–1⋅26) | 0⋅98 | 0⋅42 (0⋅24–0⋅68) | <0⋅0001 | 0⋅50 (0⋅29–0⋅82) | 0⋅0047 | |||
| bla TEM-1_4 | 1⋅19 (0⋅85–1⋅67) | 0⋅31 | 1⋅34 (0⋅96–1⋅89) | 0⋅085 | 0⋅88 (0⋅47–1⋅51) | 0⋅66 | 1⋅10 (0⋅59–1⋅90) | 0⋅74 | |||
| bla TEM-1_other | 2⋅13 (1⋅52–3⋅04) | <0⋅0001 | 2⋅29 (1⋅62–3⋅28) | <0⋅0001 | 1⋅73 (1⋅09–2⋅66) | 0⋅021 | 1⋅98 (1⋅23–3⋅07) | 0⋅0057 | |||
| bla CMY-2 | 23⋅7 (3⋅17–3035⋅88) | <0⋅0001 | 21⋅38 (2⋅79–2745⋅94) | <0⋅0001 | 2⋅43 (0⋅48–7⋅98) | 0⋅25 | 1⋅90 (0⋅35–6⋅65) | 0⋅41 | |||
| bla OXA-1 | 23⋅05 (9⋅13–83⋅21) | <0⋅0001 | 24⋅52 (9⋅69–88⋅65) | <0⋅0001 | 8⋅80 (5⋅55–13⋅75) | <0⋅0001 | 8⋅68 (5⋅41–13⋅72) | <0⋅0001 | |||
| bla _other | 29⋅06 (3⋅93–3707⋅68) | <0⋅0001 | 31⋅22 (4⋅21–3986⋅66) | <0⋅0001 | 14⋅52 (5⋅46–38⋅62) | <0⋅0001 | 13⋅46 (4⋅89–36⋅67) | <0⋅0001 | |||
Data are OR (95% CI), aOR (95% CI), or p value. blaTEM-1_1, blaTEM-1_2, blaTEM-1_3,and blaTEM-1_4 denote the four most common alleles of blaTEM-1 in the dataset (all others are denoted as blaTEM-1_other). blaTEM-1_1 is the reference version of the gene (ie, 100% nucleotide match to the version found in the AMRFinder database). In the multivariable models, estimates are adjusted for the independent presence of the two most common β-lactam–β-lactamase inhibitor resistance-conferring ARGs (blaCMY-2, blaOXA-1, and of any other β-lactam–β-lactamase inhibitor ARGs grouped as blaother). aOR=adjusted odds ratio. ARG=antibiotic-resistance gene. OR=odds ratio.